Skip to main content
Fig. 2 | Surgical and Experimental Pathology

Fig. 2

From: Prognostic values and clinical implications of programmed cell death-ligand 1 (PD-L1), fork head transcription factor P-1 (FOXP-1) and signal transducer and activator of transcription-3 (STAT-3) expression in diffuse large B-cell lymphoma (DLBCL); an immunohistochemical study

Fig. 2

Immunohistochemical expression of Fork head transcription factor (FOXP-1); (a) High nuclear FOXP-1 expression in DLBCL stage IV × 400 (b) High nuclear FOXP1 expression in DLBCL stage III × 400 (c) negative nuclear FOXP-1 expression in DLBCL stage I × 400. (d) Positive nuclear FOXP-1 expression in sections from squamous cell carcinoma of the cervix as appositive control of the marker × 400 (e) Negative control by replacement of the primary anti-FOXP-1 antibody by phosphate buffered saline × 400

Back to article page